Zobrazeno 1 - 10
of 32
pro vyhledávání: '"András Harsányi"'
Autor:
Maria Kamusheva, Manoela Manova, Alexandra T. Savova, Guenka I. Petrova, Konstantin Mitov, András Harsányi, Zoltán Kaló, Kristóf Márky, Pawel Kawalec, Bistra Angelovska, Dragana Lakić, Tomas Tesar, Pero Draganic, Mary Geitona, Magdalini Hatzikou, Marian S. Paveliu, Agnes Männik
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Objectives: The aim of the study was to compare the access of patients with rare diseases (RDs) to biotechnological drugs in several Central and Eastern European countries (CEECs). We focused on the legislative pricing and reimbursement requirements,
Externí odkaz:
https://doaj.org/article/be8ef423712946f5aac5134bb2ec1d6a
Autor:
Tea Strbad, Igor Banović, András Harsányi, Luka Voncina, Dragana Atanasijević, Jurij Fürst, Megi Vila, Ana Bobinac, Maria Kamusheva, Kristina Hristova, Maria Dimitrova, Ileana Mardare
Publikováno v:
Applied Health Economics and Health Policy. 19:915-927
Background Efficiency and transparency of pricing and reimbursement (P&R) rules and procedures as well as their implementation in South-eastern Europe (SEE) lag substantially behind Western European practice. Nevertheless, P&R systems in SEE are rare
Autor:
Mikael Hoffmann, Stuart McTaggart, Vanda Marković-Peković, Irene Langner, Skule Ingeberg, Iva Selke Krulichová, Carol Holmes, Juraj Slabý, Brian Godman, Biljana Tubić, Svens Henkuzens, Corinne Zara, Jakub Rutkowski, Jurij Fürst, András Inotai, Stephen Campbell, Konstantin Tachkov, Sean MacBride-Stewart, Ileana Mardare, Mihajlo Jakovljevic, Kristina Garuolienė, Marta Turu Pedrola, Øyvind Melien, Gisbert Selke, Magdalene Wladysiuk, Björn Wettermark, Amanj Kurdi, Arianit Jakupi, Caridad Pontes, Vasileios Kourafalos, Manfred Hinteregger, Eleonora Allocati, Radka Nejezchlebova, Guenka Petrova, Francis Kalemeera, Rita Banzi, András Harsányi, Patricia Vella Bonanno, Ott Laius, Robert Sauermann, Alice Pisana, Jolanta Gulbinovič, Anna Nachtnebel, Iris Hoxha
Publikováno v:
BioMed research international, London : Hindawi Ltd., 2021, vol. 2021, art. no. 9996193, p. [1-16]
BioMed Research International
BioMed Research International, Vol 2021 (2021)
BioMed Research International
BioMed Research International, Vol 2021 (2021)
Background. Diabetes mellitus rates and associated costs continue to rise across Europe enhancing health authority focus on its management. The risk of complications is enhanced by poor glycaemic control, with long-acting insulin analogues developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f71eb049d04b088f4f63846e1ca06c
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US
Autor:
I. Banovic, D. Atanasijevic, L. Vončina, T. Strbad, Maria Kamusheva, K. Hristova, I. Mardare, M. Vila, Maria Dimitrova, Jurij Fürst, Ana Bobinac, András Harsányi
Publikováno v:
Value in Health. 24:S180-S181
Publikováno v:
Value in Health Regional Issues. 13:16-22
We present a brief overview of the health care system in Hungary, focusing particularly on the pricing and reimbursement procedures of medicines. The National Institute of Health Insurance Fund Management is responsible for the administration of the
Autor:
Piotr Ozieranski, Zoltán Kaló, András Harsányi, Martin McKee, Olga Löblová, Lawrence King, Marcell Csanádi
Publikováno v:
Csanádi, M, Löblová, O, Ozieranski, P, Harsányi, A, Kalo, Z, McKee, M & King, L 2019, ' When health technology assessment is confidential and experts have no power: the case of Hungary ', Health Economics, Policy and Law, vol. 14, no. 2, pp. 162-181 . https://doi.org/10.1017/S1744133118000051
Health technology assessment (HTA) is not simply a mechanistic technical exercise as it takes place within a specific institutional context. Yet, we know little about how this context influences the operation of HTA and its ability to influence polic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b4b1302321affac4370fab0e7c690b
https://purehost.bath.ac.uk/ws/files/160098635/Manuscript_HTA_submission_02_08_2017_revised_version_2017_10_30_authors.pdf
https://purehost.bath.ac.uk/ws/files/160098635/Manuscript_HTA_submission_02_08_2017_revised_version_2017_10_30_authors.pdf
Autor:
Marcell Csanádi, Kristóf Márky, Zoltán Kaló, Áron Zoltán Vincziczki, András Inotai, András Harsányi
Publikováno v:
EXPERT REV PHARMACOECON OUTCOMES RES EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH IN PRESS.
Objectives: Utilization of multisource biological (off-patent originator and its biosimilar) medicines can improve the efficiency of resource allocation by 1) generating savings while maintaining health outcomes or 2) increasing the number of patient
Publikováno v:
Journal of Behavioral Addictions
Background: Obsessive–compulsive disorder (OCD) is characterized by intrusive thoughts and repetitive behaviors that severely encumber daily functioning. OCD patients seem to exhibit sleep disturbances, especially delayed bedtimes that reflect disr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1aeb531407893492664e25e998d0136
https://ueaeprints.uea.ac.uk/id/eprint/66297/
https://ueaeprints.uea.ac.uk/id/eprint/66297/
Publikováno v:
Psychiatry Research. 215:651-658
Impairments in executive functioning have been identified as an underlying cause of Obsessive-Compulsive Disorder (OCD). Obsessive patients attempt to suppress certain unwanted thoughts through a mechanism that Wegner referred to as 'chronic thought
Autor:
András Harsányi, Katalin Földesi, Katalin Csigó, Ferenc Kemény, Mihály Racsmány, Gyula Demeter
Publikováno v:
European Neuropsychopharmacology. 28:763-764
Introduction Prospective memory (PM) is defined as the ability to formulate, retain and carry out intentions, plans and promises at the appropriate time or in the appropriate context. Previous studies found evidence that patients with obsessive compu